Archimed
 
 
 
  • About Us
  • Fund
  • Support
  • Return
  • About Us
  • Fund
  • Support
  • Return
  • Our DNA
  • News
  • Join Our Team
  • Contact
  • Investor Portal
  • Our Eco-design Approach

NEWS

ARCHIMED buys Cube, an innovative provider of membrane protein services for the biopharma research market

 November

 3, 

2021

ARCHIMED refinances Ad-Tech less than a year after purchase, returning more than a third of investment to shareholders

 October

 20, 

2021

ARCHIMED’s NAMSA returns more than a third of investment

 October

 7, 

2021

ARCHIMED backs Xpress Biologics, a leading provider of plasmid DNA for advanced therapy medicinal products

 October

 5, 

2021

ARCHIMED closes MED III at €650 million hard cap in less than two months

 August

 5, 

2021

ARCHIMED’s NAMSA consolidates leadership in Medical Device Clinical Research, buying Clinlogix

 August

 2, 

2021

< 1 2 3 4 5 … 12 >
  • ARCHIMED © 2022
  • Legal Notice
  • SFDR Disclosures
  • Contact Us
  • LinkedIn
    Go top

    Back to top